about
Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithiumMood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitementProceedings: Selective effects of lithium on two forms of spontaneous activity.Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine ReceptorsStimulants: interaction with clinically relevant drugs.The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.Lithium suppression of tau induces brain iron accumulation and neurodegeneration.Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens.Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarctsVoluntary lithium intake, antidotal thirst' and concurrent behavior of rats.Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium.Chronic oral carbamazepine treatment elicits mood-stabilising effects in mice.Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system.Postsynaptic supersensitivity and kindling: further evidence of similarities.
P2860
Q30362607-81A6D39B-243E-45FD-9A4F-80881B0A40CAQ30473236-94FC44B9-0BB9-4516-9D8A-D548EC898E40Q30474415-A8FD217A-0F54-4931-9878-EC468D757C28Q30484058-C99D6B52-4CD2-41F2-B962-D320F720CF9AQ35174503-510F7272-BBAF-4A91-ABD6-1C6DAE7D1FC6Q35505900-8391CA60-A340-4201-9928-414678422EA8Q35570924-3A963EDE-8D2E-4716-8D89-94AB6B2CD397Q36293345-34BF66E0-0391-43B3-AE78-2483E2BA1E81Q36680959-BB1E6206-1335-45D1-81D0-10B2C5638469Q37416273-1AA58EE4-C0C4-4593-B6CE-6ED32900C8A6Q38412707-FCDAD94D-2C58-4169-84E9-CBF0A62C7786Q39499650-C2B63746-0083-405B-8953-F279A88FE83AQ39993032-470F3D3B-D5B7-443C-AC42-AB4EBB3E060DQ40006558-78D998B2-AC69-456E-9A62-178FD25D3C27Q40262756-A9319326-440C-41EC-9A70-61EDB33278C0Q47827825-5F837219-B682-45A4-AE38-8139FFFAC087Q50884859-2D0D1D07-42B3-41E7-BD8F-578182510A3EQ52707325-FDC18521-94D7-4BE7-AAED-87C2BAF5787F
P2860
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh-hant
name
Lithium attenuates drug-induced hyperactivity in rats.
@en
Lithium attenuates drug-induced hyperactivity in rats.
@nl
type
label
Lithium attenuates drug-induced hyperactivity in rats.
@en
Lithium attenuates drug-induced hyperactivity in rats.
@nl
prefLabel
Lithium attenuates drug-induced hyperactivity in rats.
@en
Lithium attenuates drug-induced hyperactivity in rats.
@nl
P2093
P356
P1433
P1476
Lithium attenuates drug-induced hyperactivity in rats.
@en
P2093
Harrison-Read PE
Steinberg H
Tomkiewicz M
P2888
P304
P356
10.1038/232336A0
P407
P577
1971-07-01T00:00:00Z
P6179
1013488202